C-Reactive Protein in Atherosclerosis—More than a Biomarker, but not Just a Culprit
C-reactive protein (CRP) is a pentraxin that is mainly synthesized in the liver in response to inflammatory cytokines. It exists in two functionally and structurally distinct isoforms. The first is a highly pro-inflammatory and mostly tissue-bound monomeric isoform (mCRP). The second is circulating...
Main Author: | Kürsat Kirkgöz |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-10-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/RCM/24/10/10.31083/j.rcm2410297 |
Similar Items
-
Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons
by: Munuswamy R, et al.
Published: (2021-09-01) -
Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities
by: Lawrence A. Potempa, et al.
Published: (2022-09-01) -
Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives
by: Ivan Melnikov, et al.
Published: (2023-01-01) -
Biochemically prepared C-reactive protein conformational states differentially affect C1q binding
by: Carrie L. Moon, et al.
Published: (2022-01-01) -
Monomeric C-reactive protein as a biomarker for major depressive disorder
by: Mary G. Hornick, et al.
Published: (2024-01-01)